Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Why conversations on gender in drug development must go further.

What did switching from client to constructor teach a seasoned biotech professional?

Could dry vaccines help improve global access to the latest vaccine technologies?

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

What does the future hold for lipid nanoparticles?

Fake tweet announcing free insulin leads to mayhem.

Historic challenges in ADC Development have not thwarted some players